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Abstract
In contrast to all other viruses that use the host machinery located in the endoplasmic reticulum and Golgi to glycosylate their glycoproteins, the large dsDNA-containing
chlorella viruses encode most, if not all, of the components to glycosylate their major
capsid proteins. Furthermore, all experimental results indicate that glycosylation occurs independent of the endoplasmic reticulum and Golgi.
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1. Virus-encoded glycosyltransferases
Structural proteins of many viruses, such as rhabdoviruses, herpesviruses, poxviruses, and paramyxoviruses are glycosylated. Most virus glycoproteins, which can have very complex glycans, are linked to Asn via Nacetylglucosamine, although some viruses have O-linked sugars attached
to Ser or Thr residues via an amino sugar, usually acetylglucosamine or
acetylgalactosamine. Typically, viruses use host-encoded glycosyltransferases and glycosidases located in the endoplasmic reticulum (ER) and
Golgi apparatus to add and remove N-linked sugar residues from virus
glycoproteins either co-translationally or shortly after translation of the
protein. This post-translational processing aids in protein folding and involves other host-encoded enzymes such as protein disulfide isomerase.
After folding and assembly, virus glycoproteins are transported by host
sorting and membrane transport functions to virus specified regions in
host membranes where they displace host glycoproteins. Progeny viruses then bud through these virus-specific target membranes, which
is usually the final step in the assembly of infectious virions [1–4]. Thus,
nascent viruses only become infectious by budding through the membrane, usually the plasma membrane, as they are released from the cell.
Consequently, the glycan portion of virus glycoproteins is host-specific.
The theme that emerges from these studies is that virus glycoproteins
are synthesized and glycosylated by the same mechanisms as host glycoproteins. Therefore, the only way to alter glycosylation of virus proteins is to either grow the virus in a different host or have a mutation in
the virus protein that alters the protein glycosylation site.
One outcome of this scenario is that, in general, viruses lack genes
encoding glycosyltransferases. However, a few virus-encoded glycosyltransferases have been reported in the last few years (see review [5]).
Sometimes these virus-encoded glycosyltransferases add sugars to compounds other than proteins. For instance, some phage-encoded glycosyltransferases modify virus DNA to protect it from host restriction endonucleases (e.g., [6–8]), and a glycosyltransferase encoded by baculoviruses
modifies a host insect ecdysteroid hormone leading to its inactivation [9].
Bovine herpesvirus-4 encodes a β-1,6-N-acetyl-glucosaminyltransferase
that is localized in the Golgi and is probably involved in post-translational modification of virus structural proteins [10–12]. Additional putative virus-encoded glycosyltransferases of unknown function include
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certain pox viruses [13,14], Ectocarpus siliculosus virus 1 [15], Ostreococus virus OsV5 [16], Acanthamoeba polyphaga Mimivirus [17], and
two Archaea viruses, Acidianus filamentous virus 3 [18], and Sulfolobus virus STSV1 [19]. With the rapid increase in sequencing virus genomes, additional virus-encoded glycosyltransferases will undoubtedly
be discovered.
One group of viruses that differs from the scenario that viruses use
the host machinery located in the ER and Golgi to glycosylate their glycoproteins is the chloroviruses (family Phycodnaviridae) that infect eukaryotic algae. Phycodnaviruses are large (150 to 190 nm in diameter)
polyhedral, dsDNA-containing viruses with an internal lipid membrane
(genomes of 170 to 560 kb) [20–23]. They are present in aqueous environments throughout the world and play dynamic, albeit largely unknown, roles in regulating algal communities in aqueous environments,
such as the termination of massive algal blooms commonly referred to
as red and brown tides (e.g., [24–27]). Some phycodnaviruses encode
as many as 600 proteins, which is more protein-encoding genes than in
the smallest bacteria.
The phycodnaviruses probably have a common ancestor with the
poxviruses, iridoviruses, African swine fever virus, and Mimivirus (e.g.,
[28–30]), and accumulating evidence indicates that the phycodnaviruses
have a long evolutionary history, possibly dating from the time eukaryotes arose from prokaryotes (2–3billion years ago) (e.g., [30– 32]). Some
algal virus genes encode commercially important enzymes such as DNA
restriction endonucleases (e.g., [33,34]), whereas other viral genes encode proteins that are the smallest in their class and may represent the
minimal catalytic unit. Consequently, these ‘small’ proteins serve as models for mechanistic and structural studies (e.g., DNA topoisomerase type
II [35] and a K+ ion channel protein [36]).
Phycodnavirus members in the genus Chlorovirus are plaque forming viruses that infect certain isolates of unicellular, chlorella-like green
algae. The prototype chlorella virus Paramecium bursaria chlorella virus (PBCV-1) infects a host, Chlorella NC64A, that is normally a symbiont in the protozoan P. bursaria. The 330 kb PBCV-1 genome has ~690
potential open reading frames (ORFs) of 65 codons or larger [20]. About
365 of these ORFs are predicted to encode proteins (CDSs) and the functions of 35–40% of these CDSs have been tentatively identified. Pertinent to this review is that 17 of the PBCV-1 genes encode enzymes that
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manipulate sugars, many of which have never been found previously
in a virus (Table 1). At least five of the enzymes are putative glycosyltransferases, presumably involved in glycosylation of the PBCV-1 major
capsid protein Vp54. [Note: in our original report on the annotation of
the PBCV-1 genome we identified 7 PBCV-1 encoded glycosyltransferases [37]. However, two of these CDSs, which were co-linear with an adjacent glycosyltransferase, were the result of sequencing errors and are
part of the adjacent glycosyltransferase.]
Table 1. Virus PBCV-1 encoded enzymes involved in sugar manipulation.
Activity
CDS
		

Size
(aa)

Expresseda Reference
(min p.i.)

Glycosyltransferases
A064R

A111/114R

638

20–60

[60]

517

20–60

–

860

40–60

A219/222/226R
Hyaluronan biosynthesis

A546L

677

UDP-glucose dehydrogenase

A609L

20–40

[42]

Sugar nucleotide biosynthesis

A098R

389

GDP-d-mannose 4,6 dehydratase

A118R

345

40–90

[46]

A473L

Glutamine:fructose-6-PO4 amidotransferase
Hyaluronan synthase
Fucose synthase

b

Polysaccharide degrading enzymes
Chitinase
Chitinase

Chitosanase

β-1,3-glucanase

β and α 1,4-linked glucuronic lyase
Others

D-lactate dehydrogenase

Pyrimidine dimer-specific glycosylase

A100R

396

595

568

20–60

–

40–60

20–60

20–40

–

–

[42]

[38]

A295L

317

40–90

[46]

A181/182R

830

60–360

[49]

A260R

484

90–360

A292L

328

321

120–360

A053R

363

20–60

A094L

A215L
A050L

364

141

90–360
20–40

20–60

[49]

[49]

[50]

[51]
–

[52]

a. The time the genes were expressed was determined by microarray analysis (Yanai-Balser, G.M.
et al., manuscript in preparation).
b. Another name is GDP-4-keto-6-deoxy-d-mannose epimerase reductase.
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2. Chlorovirus-encoded sugar enzymes
Three PBCV-1 encoded enzymes are involved in the synthesis of the extracellular matrix polysaccharide hyaluronan (also referred to as hyaluronic acid), including the glycosyltransferase hyaluronan synthase
(HAS) [38,39]. Hyaluronan, a ubiquitous constituent of the extracellular
matrix in vertebrates, consists of ~20,000 alternating β-1,4-glucuronic
acid and β-1,3-N-acetylglucosamine residues [40]. Hyaluronan synthesis
occurs at the plasma membrane and is simultaneously extruded through
the membrane to the exterior of the cell. Until the has gene was discovered in PBCV-1, hyaluronan was thought to only occur in vertebrates and
a few pathogenic bacteria, where it forms an extracellular capsule, presumably to avoid the immune system [40,41].
PBCV-1 also encodes two enzymes involved in the biosynthesis of
hyaluronan precursors, glutamine:fructose-6-phosphate amidotransferase and UDP-glucose dehydrogenase [42]. All three genes are expressed early during PBCV-1 infection. These results led to the discovery that hyaluronan lyase-sensitive hair-like fibers begin to accumulate
on the surface of PBCV-1 infected host cells by 15 min post infection
(p.i.). By 4 h p.i., the infected cells are covered with a dense fibrous hyaluronan network [39].
The has gene is present in many, but not all, chloroviruses isolated
from diverse geographical regions [39]. Surprisingly, many chloroviruses that lack a has gene have a gene encoding a functional chitin synthase (CHS). Furthermore, cells infected with these viruses produce
chitin fibers on their external surface [43]. Chitin, an insoluble linear
homopolymer of β-1,4-linked N-acetyl-glucosamine residues, is a common component of insect exoskeletons, shells of crustaceans and fungal cell walls [44].
A few chloroviruses contain both has and chs genes, and form both hyaluronan and chitin on the surface of their infected cells [43,45]. Finally,
a few chloroviruses probably lack both genes because no extracellular
polysaccharides are formed on the surface of cells infected with these
viruses [39]. The fact that many chloroviruses encode enzymes involved
in extracellular polysaccharide biosynthesis suggests that the polysaccharides, which require a huge expenditure of ATP for their synthesis,
are important in the virus life cycle. However, at present this function(s)
is unknown.
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The chloroviruses encode additional enzymes involved in nucleotide sugar metabolism. Two enzymes encoded by virus PBCV-1, GDP-dmannose 4,6 dehydratase (GMD) and a GDP-4-keto-6-deoxy-d-mannose
epimerase reductase (GMER) comprise the highly conserved pathway
that converts GDP-d-mannose to GDP-L-fucose. In vitro reconstruction
of the biosynthetic pathway using recombinant PBCV-1 GMD and GMER
synthesized GDP-L-fucose [46,47]. Unexpectedly, however, the PBCV-1
GMD also catalyzes the NADPH-dependent reduction of the intermediateGDP-4-keto-6-deoxy-d-mannose, forming GDP-d-rhamnose. Both
fucose and rhamnose are constituents of the glycans attached to the
PBCV-1 major capsid protein Vp54 (see below). Therefore, the virus
might encode the enzymes to meet this need. Other chloroviruses encode additional sugar-metabolizing enzymes including a putative mannose-6-phosphate isomerase and a UDP-glucose 4,6 dehydratase [48]
(Tonetti, M. et al., unpublished data).
At least five PBCV-1-encoded enzymes are involved in polysaccharide
degradation, including 2 chitinases, a chitosanase, a β-1,3-glucanase, and
a β- and α-1,4-linked glucuronic acid lyase (summarized in [21], [49–
51]). Finally, one enzyme is a glycosylase that initiates pyrimidine photodimer excision [52,53].
3. Glycosylation of virus PBCV-1 major capsid protein Vp54
The major capsid protein of PBCV-1, Vp54 (comprises ~40% of total virus
protein), is a glycoprotein with a molecular weight of 53,790 (Table 2).
Glycosylation of Vp54 and two minor structural proteins Vp280 (~1% of
the total virus protein) and Vp260 (~0.1% of total virus protein) differs
from other viruses. CDS A430L encodes Vp54 with a predicted molecular weight of 48,165 Da. This protein undergoes additional post-translational modifications in addition to being glycosylated. The aminoterminal Met is removed [54] and the protein is myristylated in the
carboxyl-terminal portion of the protein, probably at an internal Lys
or Arg [55]. Vp260 is coded by CDS A122/123R, a protein of 138 kDa.
Since the protein migrates on SDS-PAGE with a weight of ~260 kDa, it
probably consists of more than 40% carbohydrate. The CDS encoding
Vp280 is unknown.

Va n E t t e n e t a l . i n B i o c h i m i c a e t B i o p h y s i c a A c ta 1 8 0 0 ( 2 0 1 0 )

7

Table 2. Properties of antigenic classes of viruses derived from PBCV-1. Modified from
[60].
Antigenic classes
Class

Wild-type

Properties of members of each antigenic class

Proposed
genotype

54 kDa

PBCV-1

			

EPA-2

			

P1050

P91

EPA-1

wt

Mr Vp54
Virus
MW Vp54, mass
SDS-PAGE		
spectrometry

mp91
mepa1

53 kDa
52 kDa

			
			
			
E11

mel 1

51 kDa

			
			
			
P100

mp100

50.5 kDa

P91

53,790

52,780

Total glycan
massa
5545

4535

EPA-1

51,560

3315

P31

51,593

3348

E11

nd

nd

EPA-3

P1056
P41

P1210
P1219

P100

ndb
nd

nd
nd
nd
nd
nd

51,038

nd

nd

nd
nd
nd

nd

nd

2793

a. Calculated by subtracting the deduced peptide mass minus the N-terminal initiating Met residue (48,017) and the mass of one myristate (228.4) from the MW determined by mass spectrometry. All the protein backbones are identical.
b. nd, not determined.

Cryo-electron microscopy and three-dimensional (3-D) icosahedral
image reconstruction of the PBCV-1 virion indicate that the outer capsid
is icosahedral and covers a lipid bilayered membrane [56,57]. The capsid shell consists of 1680 donut-shaped trimeric capsomers plus 12 pentameric capsomers at each icosahedral vertex. The trimeric capsomers
are arranged into 20 triangular facets (trisymmerons, each containing
66 trimers) and 12 pentagonal facets (pentasymmetrons, each containing 30 trimers and one pentamer at the icosahedral vertices). Trisymmetrons and pentasymmetrons are made up of trimeric capsomers, with
each doughnut shaped capsomer composed of 3 monomers of Vp54.
The trimeric capsomers are easy to isolate because heating PBCV-1 to
65 °C for a few minutes leads to solubilization of the trimers. However,
the monomer form of Vp54 is insoluble.
Recent five-fold symmetry, rather than icosahedral, averaging of cryoelectron microscopy data has produced some exciting results on the
structure of PBCV-1 [58]. PBCV-1 has a unique pentameric vertex with
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a 250 Å long and 50 Å wide cylindrical spike that connects to a large
pocket between the capsid and the enveloped nucleocapsid. Circumstantial evidence suggests that Vp260 may be a component of the spike
structure, which presumably is involved in virus attachment.
The conclusion that the PBCV-1 proteins are glycosylated by a different mechanism than those used by other viruses originally arose
from antibody studies. Polyclonal antiserum prepared against intact
PBCV-1 virions inhibits virus plaque formation by agglutinating particles. Spontaneously derived, antiserum-resistant, plaque-forming variants of PBCV-1 occur at a frequency of 10−5 to 10−6. These antiserum-resistant variants fall into four serologically distinct classes (Table 2) [59].
Polyclonal antisera prepared against members of each of these antigenic
classes react exclusively or predominately with the Vp54 (and Vp280 and
Vp260) equivalents from the viruses in the class used for the immunization. While each of the three glycoproteins from the antigenic variants
migrate faster on SDS-PAGE than those of the strains from which they
are derived, all of the major capsid proteins co-migrate after deglycosylation. Western blot analyses of Vp54 proteins isolated from the variants, before and after removing the glycans with trifluoromethane-sulfonic acid or altering the glycan with periodic acid, established that the
antigenic variants reflect differences in the Vp54 glycans. In addition,
the ratio of the seven neutral sugars [glucose, fucose, galactose, mannose, xylose, rhamnose and arabinose [59] attached to PBCV-1 Vp54 and
the variants change in a manner that correlates with antigenicity and
Vp54 migration on SDS-PAGE (Table 3). Variants from different classes
can complement and recombine in dual infection experiments to produce wild-type progeny, indicating that the enzymes involved in glycosylation reside in different virus-encoded complementation groups [60].
Additional observations indicate that Vp54 glycosylation is unusual:
i) unlike viruses that acquire their glycoprotein(s) by budding through
a plasma membrane, intact infectious PBCV-1 particles accumulate inside the host 30–40 min before virus release [61]. ii) The nucleotide sequence of the Vp54 gene (a430l) in each of the variants is identical to
wild-type PBCV-1, thus the peptide portion of Vp54 is not altered in the
mutants [59]. iii) All of the antigenic variants are grown in the same host
so the differences cannot be attributed to the host. iv) Polyclonal antibodies to Vp54 do not react with host glycoproteins. v) Neither N-acetylglucosamine (GlcNAc) nor N-acetylgalactosamine was detected in Vp54
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glycans, sugars commonly found in Asn-linked (N-linked) and many Ser/
Thr-linked (O-linked) glycoproteins produced via the cellular ER-Golgi
pathway (Table 3) [59]. vi) Unlike most glycoproteins that exhibit size
microheterogeneity, Vp54 appears homogeneous on SDSPAGE; in addition, mass spectrometry analysis only reveals one satellite peak that differs in molecular weight by 140 Da, the approximate weight of either one
arabinose, xylose, fucose or rhamnose sugar (Cerny, R. and Van Etten,
J.L., unpublished data). vii) The ability to easily crystallize Vp54 as a homotrimer provides additional evidence that the protein is essentially
homogeneous (Fig. 1) [62].
The glycans are not linked to the major capsid proteins by a traditional N-linkage because: i) treatment of Vp54 with the enzymes endo-βN-acetylglucosaminidase F or N-glucosidase F, which cleave glycans from
N-linked glycoproteins [63], does not alter Vp54 migration on SDS-PAGE
(Chaney, W.G. and Van Etten, J.L., unpublished data). ii) The drug tunicamycin, which inhibits synthesis of N-linked glycoproteins [64], has no
effect on PBCV-1 replication nor Vp54 electrophoretic mobility, even at
concentrations three times that required to inhibit host chlorella growth
[55]. Finally, an antibody (provided by Felix Wieland) to a β-glucose Asn
linkage present in bacterial glycoproteins [65] reacts strongly with Vp54
(Gurnon, J.R. and Van Etten, J.L., unpublished data), suggesting that one
Table 3. Sugar composition of the glycoproteins from PBCV-1 serotypes. (Reproduced
from [59]).
Sugar

Fucose

Ara/Rham
Galactose
Glucose
Xylose

Mannose

Viruses — relative sugar content

a

PBCV-1

P91

EPA-1

P31

P41

E11

P100

0.69

0.73

0.88

0.81

0.78

0.83

0.61

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.57

1.02
1.58
1.02

1.24

0.97
1.47
0.70

0.64

1.02
1.59
0.14

0.65

1.03
1.57
0.17

0.65

0.99
0.88
0.24

0.65

0.97
0.77
0.15

0.19

0.91
0.60
0.12

Values are normalized to that of glucose. The mutants are arranged so that the major capsid protein decreases in size from PBCV-1 to P100. Viruses EPA-1 and P31 and viruses P41 and E11
are serologically similar even though they are separate isolates. Viruses P91, EPA-1, P31 and
P41 are derived from PBCV-1; virus E11 is derived from EPA-1; and virus P100 is from P31.
Ara/Rham, arabinose/rhamnose.
a. Subsequent experiments established that both Ara and Rham are present in the PBCV-1 major capsid protein.
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Fig. 1. A ribbon diagram of the crystal structure of the virus PBCV-1 major capsid protein, Vp54, monomer with strategic amino acids labeled. The carbohydrate moieties (yellow) and glycosylated Asn and Ser residues (blue and gray, respectively)
are shown as space-filling atoms. The green and red regions indicate the consecutive “jelly roll” domains of the protein. The arrow shows the orientation of the protein from the inside to the outside of the virus. Reproduced from [62].

or more of the Asn-linked glycans in Vp54 have this linkage. This same
linkage exists in the B2 chain of mammalian laminin, a major basement
membrane glycoprotein [66].
We originally suggested that Vp54 had a single ~30mer glycan or
two-15mer glycans attached to it [60]. However, the Vp54 crystal structure revealed sugars attached to six amino acids in the protein (Fig. 1)
[62]. Comparison of the molecular mass of Vp54 (53,790 Da) with its
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predicted molecular weight from the amino acid sequence (48,165 Da)
indicates that the protein contains 30–35 sugar moieties, of which 20
could be detected, but not identified, in the crystal density map. At a
minimum, single sugars were found attached to Ser57 and Ser387; six and
seven-branched chain sugar moieties were found attached to Asn280 and
Asn302, respectively, as well as three and two sugar residues were located at Asn399 and Asn406, respectively. As predicted from the antibody
results, the four N-linked glycans are on the external surface of the virus. GlcNAc fits the carbohydrate electron density at residues Asn280,
Asn302, and Asn399. However, the inability to detect GlcNAc in Vp54 suggests that another modified sugar might be in this position, e.g., glucose
with an O-linked acetate.
The identification of the glycan-linked Asn residues in Vp54 provided
additional evidence that Vp54 glycosylation does not involve host glycosyltransferases. Asn302, Asn399, andAsn406 occur in the amino acid sequence
(A/G)NTXT, and Asn280 occurs in an ANIPG sequence. None of these Asn
residues resides in a NX(T/S) sequence commonly recognized by ER located glycosyltransferases [67]. These findings also explain why previous enzymatic tests for N-glycosylation were negative. Finally, the major
capsid protein, like the glycosyltransferases, lacks an ER or Golgi signal
peptide. Therefore, taken together, the results suggest that PBCV-1 encodes some, if not all, of the enzymes involved in constructing the glycans attached to Vp54.
4. PBCV-1 encoded glycosyltransferases
As mentioned above, five putative glycosyltransferase-encoding genes
have been found in PBCV-1, which are scattered throughout the PBCV-1
genome (Table 1). None of these PBCV-1 encoded glycosyltransferases
has an identifiable signal peptide that would target them to the ER. Furthermore, the cellular protein localization program PSORT predicts that
all of these proteins, with the exception of A473L, are located in the cytoplasm. A473L is predicted to contain one transmembrane domain.
The genes for all five PBCV-1 encoded glycosyltransferases are expressed early during PBCV-1 infection (Yanai-Balser, G.M. et al., manuscript in preparation). Thus, assuming the proteins are stable, the enzymes should be available for either adding sugars to the Vp54 glycans
or transferring the glycans. The a430l gene is expressed late.
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4.1. PBCV-1 a64r gene
The PBCV-1 a64r gene encodes a 638 amino acid protein with 4 motifs
that are conserved in the “fringe-class” of glycosyltransferases [68,69].
Five conserved domains, designated 1–5, have been identified in this
class of enzymes [69]. Domains 3 and 5 contain the proposed catalytic
amino acids, the “DXD” sequence in domain 3 and the first “D” residue in
domain 5. The A64R protein contains domains 2–5 although the spacing
between some of the domains differs from that of fringe-glycosyltransferases. As mentioned above, the A64R protein lacks both an identifiable
signal peptide that would target the protein to the ER and a membranespanning domain in contrast to fringe-glycosyltransferases.
Analysis of 13 PBCV-1 antigenic variants revealed mutations in a64r
that correlated with a specific antigenic class, EPA-1 (Table 2). The a64r
gene in six of these antigenic variants was sequenced to determine if mutations in a64r correlated with the EPA-1 antigenic variation [60]. The
a64r sequences from mutants EPA-1, EPA-3, and P31 have single nucleotide substitutions, which produce a single amino acid substitution in
the A64R protein. Two of the amino acid substitutions occur in the DXD
motif (domain 3) and the other one is in domain 4. A fourth variant has
an extra base in the coding sequence, which creates a frame shift mutation in the gene. Finally, the entire gene is deleted in the other two antigenic variants.
Dual infection experiments with the different antigenic variants indicate that viruses containing wild-type a64r complement and recombine
with viruses that contain variant a64r to form wild-type virus. Therefore, we concluded that a64r encodes a glycosyltransferase involved in
the synthesis of the Vp54 glycan [60].
5. Structure of PBCV-1 encoded A64R glycosyltransferase
Blast searches with the 638 amino acid A64R protein established that
the glycosyltransferase domains are located in the amino-terminal 211
amino acids. The A64R carboxyl terminus resembles several bacterial
proteins of unknown function.
The amino-terminal A64R glycosyltransferase domain (residues
1–211) was expressed in a bacterial system for crystallization studies. The crystal structure of the peptide was solved at 1.6 Å resolution
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Fig. 2. A ribbon diagram of the crystal structure of the glycosyltransferase domain from
virus PBCV-1 CDS A64R. Bound Mn2+ and citrate ions are shown in a ball-and-stick
representation. Alpha (purple) and beta sheets (pink) are color coded.

(Fig. 2) [70]. The peptide has a mixed α/β fold containing a central, sixstranded β sheet flanked by α helices. The overall fold is similar to catalytic domains of glycosyltransferases in the GT-A group, retaining glycosyltransferase family 34, although the amino acid similarity between
them is low (less than 14% for equivalent Cα atoms). Crystal structures
of A64R complexed with UDP, CMP, or GDP, established that only UDP
bound to A64R in the presence of Mn2+, consistent with its high structural similarity to glycosyltransferases that use UDP as the sugar carrier. The structure of the A64R, UDP-glucose, and Mn2+ complex showed
that the largest conformational change occurred when hydrogen bonds
were formed with the ligands. Unlike UDP-glucose, UDP-galactose and
UDP-GlcNAc did not bind to A64R, suggesting a selective binding of UDPglucose. Thus UDP-glucose is most likely the sugar donor for A64R, consistent with glucose occurring in the virus major capsid protein glycans
(Table 3).
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However, no enzymology has been conducted on the A64R peptide, or
any of the other virus-encoded glycosyltransferases because the structure of the Vp54 glycans is unknown. Consequently, the substrate(s) for
A64R or any of the putative viral glycosyltransferases are unknown.
6. Where does Vp54 acquire its glycans?
A brief description of the PBCV-1 life cycle follows. PBCV-1 infects its
host Chlorella NC64A by attaching rapidly, probably at a unique virus
vertex [58,71], to the algal cell wall, followed by degradation of the wall
at the point of attachment [72]. After digestion of the wall, the PBCV-1
internal membrane presumably fuses with the host membrane to translocate virus DNA and probably some virus associated proteins to the inside of the host, leaving an empty capsid on the surface.
Two observations suggest that upon infection PBCV-1 DNA and probably DNA-associated proteins quickly move to the nucleus and commandeer at least some of the host transcription machinery to initiate early
viral RNA synthesis; early virus transcripts can be detected within 5–10
min p.i. [73,74]. i) PBCV-1 does not encode a recognizable RNA polymerase gene(s) nor is RNA polymerase activity detected in isolated virions (Rohozinski, J. and Van Etten, J.L., unpublished data). ii) A small intron with splice-site sequences characteristic of nuclear-spliced mRNAs
exists in the PBCV-1 DNA polymerase gene [75]. Presumably, this intron
is excised in the cell nucleus.
Viral DNA synthesis begins between 60 and 90 min p.i., followed by
late viral transcription [73,76]. Virus assembly begins ~3 h p.i. in localized regions of the cytoplasm called virus assembly centers. By 6–
8 h p.i., virus induced host cell lysis occurs and results in the release of
progeny viruses (~1000 virus particles per cell of which ~25% are infectious) [72].
The intracellular location of virus protein glycosylation is unknown,
although gold-labeled Vp54 antibody only reacts with proteins in the virus assembly centers (Graves, M.V., Gurnon, J.R. and Van Etten, J.L., unpublished data). This finding suggests that Vp54 might acquire its glycans in the virus assembly centers.
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7. How are sugars added to Vp54?
The structures of the glycans attached to Vp54 are unknown and we are
happy to collaborate with anyone who wants to solve their structures.
The prediction is that the glycan structures differ from typical glycans
because it is unlikely that the host ER and Golgi apparatus are involved
in adding sugars to PBCV-1 Vp54. Vp54 lacks a recognizable ER signal
peptide and so presumably, it does not enter the ER. However, one can
ask the question: are the sugars added to Vp54 either sequentially or
are they synthesized independently of Vp54, possibly on a lipid carrier,
and then attached to the protein in a single step? A slight variation of
these two possibilities is to synthesize a core glycan(s) independently
of the protein and attach it to Vp54. This core glycan(s), which could be
either larger or smaller than the final product, is processed further after attachment to the protein.
To distinguish between these possibilities [2,6-3H]-galactose was
added to cells at the time of PBCV-1 infection and cells collected at various times p.i. [We are aware that galactose can be converted to other
products.] After disrupting the cells, SDS-soluble materials were separated on SDS-PAGE, and labeled material viewed via fluorography (Fig.
3) (Graves, M.V. and Van Etten, J.L., unpublished data). Vp54 first appears
between 60 and 90 min p.i. and is a tight homogeneous band suggesting that the fully synthesized glycans are transferred to the Vp54 peptide “en mass” [Note: the Vp54 equivalent from antigenic variant EPA-1
is easily distinguished from wild-type Vp54 even though it is only 2230
Da smaller; the slightly smaller variant Vp54 from mutant E11 can be
distinguished as well (Fig. 3)] It is interesting that a slowly migrating radioactive smear is present at the top of the gel first appearing between
15 and 30 min p.i., prior to the appearance of Vp54; the smear increases
in intensity to 90 min p.i. and then becomes less intense as Vp54 intensifies. Could this “smear” be an intermediate(s) in the synthesis of the
Vp54 glycan? Interestingly, the appearance of this smear correlates with
the expression of A64R, as well as the other putative glycosyltransferases; each of the glycosyltransferase gene transcripts begin to be detected at 20 to 40 min p.i. (Table 3; [Yanai-Balser, G.M. et al., manuscript
in preparation]). Note: the smear is absent in normal cells even after 5
h of continuous labeling (Fig. 3, lane U).

Va n E t t e n e t a l . i n B i o c h i m i c a e t B i o p h y s i c a A c ta 1 8 0 0 ( 2 0 1 0 )

16

Fig. 3. Total proteins isolated from virus PBCV-1 infected Chlorella NC64A at the indicated times (min) p.i. The infection was done in the presence of [3H]-galactose. Uninfected (lane U) cells were labeled for 300 min. Lanes labeled EPA and E11 contain total
proteins from cells at 120 min after infection with antigenic variant viruses EPA-1 and
E11. The slower migrating “smear” described in the text is indicated by the bracket.
Proteins were separated on a 7.5% SDS-PAGE, and labeled proteins visualized by autoradiography (Graves, M.V. and Van Etten, J.L., unpublished data).

Assuming the Vp54 glycan precursors are transferred “en mass”, one
predicts that they are attached to a lipid carrier such as either undecaprenol-phosphate, which is the carrier for bacterial peptidoglycans
and cell surface polysaccharides [77], or dolicholdiphosphate, which is
the carrier in eukaryotic cells [67]. It is unlikely that dolicholphosphate
is the carrier because tunicamycin, which interferes with the transfer
of UDP-N-acetylglucoseamine to dolicholphosphate [64], has no effect
on either PBCV-1 replication or Vp54 synthesis, even at concentrations
three times that required to inhibit host chlorella growth [55].
8. Glycosyltransferases coded by other chlorella viruses
Polyconal antibodies to wild-type PBCV-1 and its antigenic variants do
not react with many other independent virus isolates that infect Chlorella NC64A (NC64A viruses). This lack of crossreactivity suggests that
the major capsid proteins from these nonreacting viruses have different glycans and as such these viruses code unique glycosyltransferases.
In addition, two other related virus/ chlorella systems are available for
study, viruses that infect Chlorella Pbi (Pbi viruses) and Chlorella SAG
3.83 (SAG viruses). None of the Pbi viruses or SAG viruses reacts with
PBCV-1 antiserum.
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Table 4. Glycosyltransferase-like genes encoded by six viruses that infect three Chlorella species.

PBCV-1		
NY-2A		
AR158		
MT325		
FR483		
ATCV-1
CDS

aa

CDS

aa

CDS

aa

CDS

aa

CDS

aa

CDS

aa

A064R

632

–

–

–

–

–

–

–

–

–

–

A473L

517

A111/114R

A219/222/226R
A546L
–
–
–
–

860

B159R

860

C150R

860 M467R

321

B763L

405

C661L

396

677

–
–

–
–

C265R
–

634 M721L
– M186R

–

–

B618R

270

C559R

270

–

–

–

–

–

–

–

–
–

–
–

–
–

–
–

–
–

–
–

849

N472R

848

Z120R

846

–

–

–

–

–

604
520
–

–
–
–

N715L

N191R
–

–
–
–

629
520
–

–
–
–

Z425R

Z178L
–

Z417L
Z667L

Z823R

612
533
–

553
546
553

CDS’s listed in the source line across are considered to be orthologs. The amino acid sequences of each of them are available at
http://GreenGene.uml.edu. Viruses PBCV-1, NY-2A and AR158 infect Chlorella NC64A, viruses MT325 and FR483 infect Chlorella Pbi and virus ATCV-1 infects Chlorella SAG 3.83.

We recently sequenced and annotated five additional chlorella viruses, two more NC64A viruses [78], two Pbi viruses [79], and one
SAG virus [48]. These newly sequenced viruses encode from 3 to 6
putative glycosyltransferases (Table 4). The PBCV-1 glycosyltransferase A111/114R is the only protein with an ortholog in all of the viruses. The orthologs B618R and C559R from NC64A viruses NY-2A
and AR158, respectively, produce a high Blast score with N-acetyglucosaminyltransferases, suggesting that N-acetylglucosamine might be
present in their major capsid proteins. The major capsid proteins from
NY-2A and AR158 clearly differ from PBCV-1 Vp54 because neither virus reacts with antibodies to PBCV-1 or any of its antigenic variants.
The sugar components of the major capsid proteins have not been determined for any of these 5 newly sequenced viruses. The prediction
is that the sugars will probably differ both qualitatively and quantitatively from PBCV-1.
9. Implications
The chlorella viruses contain genes encoding a variety of glycosyltransferases, most of which, if not all, lack a recognizable ER signal peptide.
Furthermore, hundreds of these viruses can be isolated easily from natural sources. We assume that different glycosyltransferases use different
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sugars and form distinct linkages. Because all of the virus-encoded glycosyltransferases lack ER signaling domains and most of them lack transmembrane domains, the virus-encoded recombinant glycosyltransferases are likely to be soluble, which makes them easier to purify and use
as reagents for adding sugars to proteins.
10. Conclusion
Collectively, the results indicate that glycosylation of the PBCV-1 major capsid protein differs from that of other viruses and that glycosylation probably occurs independently of the ER and Golgi apparatus.
Furthermore, most, if not all, of the machinery to carry out this glycosylation is encoded by the virus. These conclusions lead to many questions including:
i) could Vp54 glycosylation reflect an ancestral pathway that existed
prior to ER and Golgi formation in eukaryotic cells?

ii) Is PBCV-1 glycosylation similar to that of O-antigen-containing bacteria, which add a precise number of sugars to the basal core
polysaccharide [80].
iii) Are the Vp54 glycan precursors synthesized and assembled on a
lipid carrier?

iv) How much diversity in the number of glycosyltransferases and glycan structures exists among chlorella viruses?
v) What is the ultimate function of the capsid protein glycan?
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